Akebia Therapeutics Announces Poster Presentation at ASN Kidney Week 2022
The poster titled, "Prevalence of Hyporesponse to Erythropoiesis-Stimulating Agents Among Medicare Patients with CKD-Related Anemia According to Absolute or Weight-Based Definitions," poster number TH-PO666, will be presented during the Anemia and Iron Metabolism session on
ASN Kidney Week 2022 attendees can visit the Akebia Booth #1721.
About Akebia Therapeutics
Akebia Therapeutics Contact
View original content to download multimedia:https://www.prnewswire.com/news-releases/akebia-therapeutics-announces-poster-presentation-at-asn-kidney-week-2022-301655111.html